Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALOX5 | P09917 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 1/20 | 0.37 |
| ▸ | TYR | P14679 | 1/20 | 0.37 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | TSHR | P16473 | 1/20 | 0.37 |
| ▸ | HTT | P42858 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.37 |
| ▸ | NR1H2 | P55055 | 1/20 | 0.35 |
| ▸ | NR1H3 | Q13133 | 1/20 | 0.35 |
| ▸ | LIPG | Q9Y5X9 | 1/20 | 0.34 |
| ▸ | PTGS2 | P35354 | 5/20 | 0.33 |
| ▸ | FAAH | O00519 | 1/20 | 0.33 |
| ▸ | BID | P55957 | 3/20 | 0.33 |
| ▸ | MCL1 | Q07820 | 3/20 | 0.33 |
| ▸ | BCL2L1 | Q07817 | 2/20 | 0.33 |
| ▸ | BAK1 | Q16611 | 2/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL199973 | 1.00 | ALOX5 (0.37) | ALOX5MEN1TP53CYP3A4MAPT | |
| SCHEMBL199840 | 0.93 | TYR (0.33) | TYR | |
| SCHEMBL201808 | 0.86 | ALOX5 (0.34) | ALOX5MEN1TP53CYP3A4MAPT | |
| SCHEMBL202225 | 0.86 | ALOX5 (0.34) | ALOX5MEN1TP53CYP3A4MAPT | |
| SCHEMBL202224 | 0.84 | ALOX5 (0.33) | ALOX5MEN1TP53CYP3A4MAPT | |
| SCHEMBL201807 | 0.84 | ALOX5 (0.33) | ALOX5MEN1TP53CYP3A4MAPT | |
| SCHEMBL199974 | 0.83 | ALOX5 (0.46) | ALOX5MEN1TP53CYP3A4MAPT | |
| SCHEMBL199938 | 0.83 | ALOX5 (0.46) | ALOX5MEN1TP53CYP3A4MAPT | |
| SCHEMBL199547 | 0.81 | GABRP (0.31) | TYR | |
| SCHEMBL199664 | 0.80 | SLC6A4 (0.32) | MAPTHTT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10230023-B2 | Color converter | BASF SE (DE) | 2019-03-12 | — | — | US | disclosed |
| EP-2718395-B1 | Novel illumination device comprising a colour converter | BASF SE (DE) | 2018-02-28 | — | — | EP | disclosed |
| US-20160284947-A1 | NOVEL COLOR CONVERTER | BASF SE (DE) | 2016-09-29 | — | — | US | disclosed |
| US-9406848-B2 | Color converter | BASF SE (DE) | 2016-08-02 | — | — | US | disclosed |
| EP-2307507-B1 | NEW AZIDE SUBSTITUTED NAPHTHYLENE OR RYLENE IMIDE DERIVATIVES AND THEIR USE AS REAGENTS IN CLICK-REACTIONS | BASF SE (DE) | 2016-04-20 | — | — | EP | disclosed |
| EP-1917311-B1 | Rylene based multiple chromophores | BASF SE (DE) | 2015-09-23 | — | — | EP | disclosed |
| US-8921558-B2 | Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions | BASF SE (DE) | 2014-12-30 | — | — | US | disclosed |
| US-8802852-B2 | Azide substituted naphthylene or rylene imide derivatives and their use as reagents in click-reactions | BASF SE (DE) | 2014-08-12 | — | — | US | disclosed |
| US-20140080220-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | BASF SE (DE) | 2014-03-20 | — | — | US | disclosed |
| US-20140073059-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | BASF SE (DE) | 2014-03-13 | — | — | US | disclosed |
| US-20080287678-A1 | Multiple Chromophores Based on Rylene | BASF AKTIENGESELLSCHAFT (DE) | 2008-11-20 | — | — | US | disclosed |
| US-20080245411-A1 | Fluorescent Solar Conversion Cells Based on Fluorescent Terylene Dyes | BASF SE | 2008-10-09 | — | — | US | disclosed |
| US-20080167467-A1 | Substituted Rylene Derivatives | BASF AKTIENGESELLSCHAFT (DE) | 2008-07-10 | — | — | US | disclosed |
| EP-1927141-A2 | FLUORESCENT SOLAR CONVERSION CELLS BASED ON FLUORESCENT TERYLENE DYES | BASF SE (DE) | 2008-06-04 | — | — | EP | disclosed |
| EP-1917311-A2 | MULTIPLE CHROMOPHORES | BASF SE (DE) | 2008-05-07 | — | — | EP | disclosed |
| EP-1904497-A1 | SUBSTITUTED RYLENE DERIVATIVES | BASF SE (DE) | 2008-04-02 | — | — | EP | disclosed |
| WO-2007138051-A1 | DIBENZORYLENETETRACARBOXIMIDES AS INFRARED ABSORBERS | BASF SE (DE) | 2007-12-06 | — | — | WO | disclosed |
| WO-2007031446-A2 | FLUORESCENT SOLAR CONVERSION CELLS BASED ON FLUORESCENT TERYLENE DYES | BASF SE (DE) | 2007-03-22 | — | — | WO | disclosed |
| WO-2007014902-A2 | MULTIPLE CHROMOPHORES BASED ON RYLENE | BASF SE (DE) | 2007-02-08 | — | — | WO | disclosed |
| WO-2007006717-A1 | SUBSTITUTED RYLENE DERIVATIVES | BASF AKTIENGESELLSCHAFT (DE) | 2007-01-18 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080167467-A1 | Substituted Rylene Derivatives | NR3C2, NR2C2, NR2E3 | ALOX5 937/4885MEN1 3308/4885TP53 4451/4885 |
| US-20140080220-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | NANS, NANP, GNE | ALOX5 2945/4885MEN1 280/4885TP53 3478/4885 |
| US-20140073059-A1 | Azide Substituted Naphthylene or Rylene Imide Derivatives and their Use as Reagents in Click-Reactions | NANS, NANP, GNE | ALOX5 2945/4885MEN1 280/4885TP53 3478/4885 |
| US-20080287678-A1 | Multiple Chromophores Based on Rylene | TDO2, PPOX, NPY1R | ALOX5 406/4885MEN1 2328/4885TP53 4614/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.